journal article·2025-06Open access

Dissolving Microneedles Embedded with Photosensitizers for Targeted Eradication of Gram‐Positive Bacteria in Multidrug‐Resistant Biofilms in Diabetic Wound Infections

Ruyan Xie, Duoyang Fan, Yanpeng Fang, Tianyu Zhu, Haohan Li, Ying Yin, Xiaohui Liu, Yeshuo Ma, Fei Chen, Wenbin Zeng

Advanced Healthcare Materials· Volume 14· Issue 15

Abstract

Abstract Chronic nonhealing wounds, common in diabetic patients, represent a major clinical challenge, causing significant morbidity and healthcare costs. Persistent bacterial biofilms are a critical obstacle to wound healing, necessitating their effective elimination to promote rapid recovery. In photodynamic antimicrobial therapy (PDAT), enhancing the interaction between the photosensitizer and bacterial biofilms is key to achieving efficient antimicrobial and antibiofilm effects. Here, a novel dissolvable microneedle patch containing a benzoxaborole (BOB)‐functionalized photosensitizer is designed, TPI‐BOB, for bacteria‐specific targeting and localized PDAT of multidrug‐resistant biofilm infections in diabetic wounds. TPI‐BOB integrates a BOB moiety for selective bacterial binding and a pyridine‐based cationic group to enhance electrostatic interactions, showing superior antimicrobial activity in Gram‐positive bacteria, particularly MRSA. To further optimize therapeutic delivery and combat biofilm‐associated infections, TPI‐BOB is incorporated into dissolvable microneedles, which rapidly disintegrate upon application to wound sites. This microneedle system facilitates localized, efficient delivery of TPI‐BOB to bacterial biofilms, where it triggers photodynamic action under white‐light irradiation. This treatment eradicates the biofilm, initiating tissue repair that reduces inflammation, promotes collagen deposition, and stimulates angiogenesis, accelerating healing. This work presents a novel strategy combining PDAT with microneedle‐mediated drug delivery, offering a promising approach for treating diabetic wounds and other biofilm‐related infections.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Wound Healing and Treatments · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Xiangya School of Pharmaceutical Sciences Central South University Changsha 410013 P. R. China

Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases Changsha 410078 P. R. China

The Affiliated Nanhua Hospital Hengyang Medical School University of South China Hengyang 421200 P. R. China

Department of Geriatrics The Third Xiangya Hospital Central South University Changsha 410083 P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Hunan Province · Scientific Research Foundation of Hunan Provincial Education Department · Health Commission of Hunan Province

References (47)

Show source-provided references
1. 10.1038/s41572-022-00377-310.1038/s41572-022-00377-3 ↗
2. 10.2337/dci23-008510.2337/dci23-0085 ↗
3. 10.1016/S2213-8587(23)00025-610.1016/S2213-8587(23)00025-6 ↗
4. 10.1016/j.jaad.2015.08.06810.1016/j.jaad.2015.08.068 ↗
5. 10.1016/j.immuni.2021.12.01310.1016/j.immuni.2021.12.013 ↗
6. 10.1016/S2542-5196(22)00254-610.1016/S2542-5196(22)00254-6 ↗
7. 10.1016/j.apsb.2023.12.01610.1016/j.apsb.2023.12.016 ↗
8. 10.1002/adfm.20230497410.1002/adfm.202304974 ↗
9. 10.1002/EXP.2021026410.1002/EXP.20210264 ↗
10. 10.1039/D0SC01351J10.1039/D0SC01351J ↗
11. 10.1039/D3BM00073G10.1039/D3BM00073G ↗
12. 10.1039/D2CC02230C10.1039/D2CC02230C ↗
13. 10.1002/EXP.2023011310.1002/EXP.20230113 ↗
14. 10.1002/chem.20190346010.1002/chem.201903460 ↗
15. 10.1021/acsomega.8b0299910.1021/acsomega.8b02999 ↗
16. 10.1002/adhm.20240177810.1002/adhm.202401778 ↗
17. 10.1016/j.addr.2018.07.01910.1016/j.addr.2018.07.019 ↗
18. 10.1002/adhm.20190150210.1002/adhm.201901502 ↗
19. 10.1002/adfm.20190549310.1002/adfm.201905493 ↗
20. 10.1016/j.bioactmat.2022.06.01810.1016/j.bioactmat.2022.06.018 ↗
21. 10.1002/adfm.20200944210.1002/adfm.202009442 ↗
22. 10.1016/j.biomaterials.2020.12002010.1016/j.biomaterials.2020.120020 ↗
23. 10.1038/s41551-022-00905-210.1038/s41551-022-00905-2 ↗
24. 10.1002/adfm.20210092410.1002/adfm.202100924 ↗
25. 10.1002/anie.20191097910.1002/anie.201910979 ↗
26. 10.1016/j.jconrel.2022.05.04510.1016/j.jconrel.2022.05.045 ↗
27. 10.1016/j.jconrel.2023.02.03010.1016/j.jconrel.2023.02.030 ↗
28. 10.1016/S0140-6736(17)30575-510.1016/S0140-6736(17)30575-5 ↗
29. 10.1016/j.addr.2021.11391910.1016/j.addr.2021.113919 ↗
30. 10.1016/j.jconrel.2022.09.02510.1016/j.jconrel.2022.09.025 ↗
31. 10.1186/s12951-024-02374-y10.1186/s12951-024-02374-y ↗
32. 10.1126/sciadv.160131410.1126/sciadv.1601314 ↗
33. 10.1002/advs.20210082710.1002/advs.202100827 ↗
34. 10.1038/s41551-019-0508-y10.1038/s41551-019-0508-y ↗
35. 10.1016/j.addr.2018.12.00610.1016/j.addr.2018.12.006 ↗
36. 10.1002/smsc.20240015810.1002/smsc.202400158 ↗
37. B.Wang N.Zhang W.Feng S.Chen X.Zhu X.Shan R.Yuan B.Yuan H.Wang G.Zhou J.Liu X.Sun Adv. Funct. Mater.2024 n/a 2407934.
38. 10.1016/j.xcrp.2022.10124510.1016/j.xcrp.2022.101245 ↗
39. 10.1016/j.bbamem.2015.11.00410.1016/j.bbamem.2015.11.004 ↗
40. 10.1038/s41586-020-2236-610.1038/s41586-020-2236-6 ↗
41. 10.1021/acsami.1c0988910.1021/acsami.1c09889 ↗
42. 10.1002/advs.20220658510.1002/advs.202206585 ↗
43. 10.1038/s41579-019-0201-x10.1038/s41579-019-0201-x ↗
44. 10.1038/s41467-023-43945-110.1038/s41467-023-43945-1 ↗
45. 10.7150/thno.7887810.7150/thno.78878 ↗
46. 10.1007/s10456-013-9381-610.1007/s10456-013-9381-6 ↗
47. 10.1038/nm.366810.1038/nm.3668 ↗